Artikel ; Online: Recent progress in drug development for fibrodysplasia ossificans progressiva.
Molecular and cellular biochemistry
2022 Band 477, Heft 10, Seite(n) 2327–2334
Abstract: Fibrodysplasia Ossificans Progressiva (FOP) is a rare genetic disease caused by heterozygous missense mutations in Activin A receptor type I which is also known as Activin-like kinase 2 (ALK2), a type I receptor of Bone Morphogenetic Proteins(BMP). ... ...
Abstract | Fibrodysplasia Ossificans Progressiva (FOP) is a rare genetic disease caused by heterozygous missense mutations in Activin A receptor type I which is also known as Activin-like kinase 2 (ALK2), a type I receptor of Bone Morphogenetic Proteins(BMP). Patients with FOP usually undergo episodic flare-ups and the heterotopic ossification in soft and connective tissues. Molecular mechanism study indicates that Activin A, the ligand which normally transduces Transforming Growth Factor Beta signaling, abnormally activates BMP signaling through ALK2 mutants in FOP, leading to heterotopic bone formation. To date, effective therapies to FOP are unavailable. However, significant advances have recently been made in the development of FOP drugs. In this article, we review the recent advances in understanding the FOP mechanism and drug development, with a focus on the small-molecular and antibody drugs currently in the clinical trials for FOP treatment. |
---|---|
Mesh-Begriff(e) | Activins/genetics ; Activins/metabolism ; Bone Morphogenetic Proteins/metabolism ; Drug Development ; Humans ; Ligands ; Mutation ; Myositis Ossificans/drug therapy ; Myositis Ossificans/genetics ; Myositis Ossificans/metabolism ; Ossification, Heterotopic/genetics ; Ossification, Heterotopic/metabolism ; Transforming Growth Factor beta/genetics |
Chemische Substanzen | Bone Morphogenetic Proteins ; Ligands ; Transforming Growth Factor beta ; Activins (104625-48-1) |
Sprache | Englisch |
Erscheinungsdatum | 2022-05-10 |
Erscheinungsland | Netherlands |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 184833-1 |
ISSN | 1573-4919 ; 0300-8177 |
ISSN (online) | 1573-4919 |
ISSN | 0300-8177 |
DOI | 10.1007/s11010-022-04446-9 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 892: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.